Teva Pharmaceutical Industries Ltd TEVA:NYSE

Last Price$10.20NYSE Previous Close - Last Trade as of 6:30PM ET 11/15/19

Today's Change+0.83(8.86%)
Bid (Size)$10.15 (10)
Ask (Size)$10.25 (2)
Day Low / High$9.37 - 10.28
Volume29.3 M

Read more news Recent News

ADR Top % Movers in Pre-Market Trading
6:46AM ET 11/15/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers BBL +1.7% RIO +1.5% NOK +1.5% TEVA +0.6% Losers HSBC -0.9% SAN -0.5% VOD -0.5% BP -0.2% GSK -0.2% STM -0.1%...

ADR Top % Movers in Pre-Market Trading
6:21AM ET 11/13/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers BUD +1.4% GSK +0.8% GPWH +0.1% Losers BBVA -3.0% HSBC -1.9% BBL -1.5% SAN -1.0% RIO -0.8% BP -0.3% TEVA...

Analyst Actions: JPMorgan Upgrades Teva Pharmaceutical Industries to Neutral From Underweight; Price Target is $8
7:44AM ET 11/12/2019 MT Newswires

Teva Pharmaceutical Industries (TEVA) has an average rating among analysts of hold, with an average price target of $10. Price: 9.28, Change: -0.05,...

ADR Top % Movers in Pre-Market Trading
6:44AM ET 11/12/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers CUK +1.2% BUD +1.0% RIO +0.2% CS +0.1% HSBC +0.1% GWPH +0.1% Losers DBVT -1.4% TEVA -1.1% NOK -0.6% BP...

Company Profile

Business DescriptionTeva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel. View company web site for more details
Address5 Basel Street
Petach Tikva, HaMerkaz 49131
Number of Employees42,535
Recent SEC Filing11/07/20198-K
President, Chief Executive Officer & DirectorKåre Schultz
Executive Vice President-Global OperationsEric Drapé
Chief Financial Officer & Executive Vice PresidentMichael McClellan
Chief Legal Officer & Executive Vice PresidentDavid Stark

Company Highlights

Price Open$9.47
Previous Close$9.37
52 Week Range$6.07 - 22.83
Market Capitalization$11.1 B
Shares Outstanding1.1 B
SectorHealth Technology
IndustryPharmaceuticals: Generic
Next Earnings Announcement02/12/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$0.29
Beta vs. S&P 500N/A
Revenue$18.8 B
Net Profit Margin-21.85%
Return on Equity-25.24%

Analyst Ratings as of 11/15/2019

Consensus RecommendationConsensus Icon
Powered by Factset